Alessandro Angelini earned his doctorate in Biochemistry and Biotechnology under the supervision of Prof. G. Zanotti at the University of Padova in 2008. Between 2008 and 2011, he was a postdoctoral researcher in the laboratory of Prof. C. Heinis at the École Polytechnique Fédérale de Lausanne (EPFL). Between 2012 and 2016, he was a research scientist in the laboratory of Prof. K.D. Wittrup at the Massachusetts Institute of Technology (MIT). Since 2017, he is a tenure-track researcher B-type (RTD-B) at the Department of Molecular Science and Nanosystems of the Ca’ Foscari University of Venice. The research topics of his group lines between basic and applied research and are related to drug discovery and evolutionary biology. His research is primarily focused on the development of novel peptides and proteins with a novel mechanism of action that have the potential to overcome the limitations of current therapeutic and diagnostic applications. Other research interests include more fundamental questions about protein evolution.
Last update: 19/07/2019